LeafNLP Demos
Back to explore

Report #2889649

Received Mar 18, 2026

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
OR
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TYPTYPHOID LIVE ORAL TY21A (VIVOTIF)BERNA BIOTECH, LTD.1Unknown—

Symptoms (1)

Product dose omission issue

Symptom narrative

The patient missed a dose of Vivotif; Case reference number US-BN-2025-00111 is a spontaneous case initially received from a pharmacist via Communication (reference number: USBAV25-1493) on 23-Jun-2025 and concerns a female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient took dose of Vivotif (batch number: unknown), at an unknown dose, route for unknown indication. As reported, the patient that missed a dose of Vivotif and would take the dose later that expected (explicitly coded as 'missed dose'). At the time of the initial report, it was unknown if the patient experienced any adverse events due to Vivotif. No further information was provided.; Reporter's Comments: A female patient of unspecified age missed a dose of Vivotif for unknown indication, which is considered as missed dose. It was unknown if the patient experienced any adverse events due to Vivotif. Product dose omission issue is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product dose omission issue is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unspecified age missed a dose of Vivotif for unknown indication, which is considered as missed dose. It was unknown if the patient experienced any adverse events due to Vivotif. Product dose omission issue is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product dose omission issue is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.

Medical history

Comments: None.